Literature DB >> 19351906

Response and progression-free survival in oropharynx squamous cell carcinoma assessed by pretreatment perfusion CT: comparison with tumor volume measurements.

S Bisdas1, Z Rumboldt, J Wagenblast, M Baghi, T S Koh, M Hambek, T J Vogl, M G Mack.   

Abstract

BACKGROUND AND
PURPOSE: Perfusion CT (PCT) provides a rapid, reliable, and non-invasive technique for assessing tumor vascularity. The purpose of this study was to assess whether pretreatment dynamic perfusion CT (PCT) may predict response to induction chemotherapy and midterm progression-free survival (PFS) in advanced oropharynx squamous cell carcinoma (SCCA) and to compare the results with those derived by tumor volume measurements.
MATERIALS AND METHODS: Nineteen patients underwent routine contrast-enhanced CT (CECT), pretreatment PCT, and conventional endoscopy. Tumor response was determined according to radiologic (RECIST) criteria. The PCT parameters, tumor volume, radiologic response, and PFS were analyzed with use of Cox-proportional hazards model, receiver operating characteristic (ROC), and Kaplan-Meier analysis.
RESULTS: The baseline blood flow (BF), blood volume (BV), and permeability surface area product (PS) were significantly higher, whereas mean transit time (MTT) was significantly lower in the responders than in the nonresponders (P < or = .002). BV showed 100% sensitivity, MTT and PS had the highest specificity (100%), and BF showed 84.2% sensitivity and 66.7% specificity for prediction of tumor response after induction chemotherapy. The pretreatment tumor volume correlated with PFS in the pooled patients group (r = 0.4; P < .0001), whereas postinduction tumor volume correlated significantly with PFS in the responders and nonresponders (r = 0.22-0.64; P < or = .006). Pretreatment tumor volume (P = .0001) and BF (P = .001) were significant predictors for PFS.
CONCLUSIONS: Pretreatment PCT parameters may predict response after induction chemotherapy. Tumor volume and BF values may predict PFS in patients with advanced oropharyngeal SCCA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351906     DOI: 10.3174/ajnr.A1449

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  10 in total

1.  Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy.

Authors:  M T Truong; N Saito; A Ozonoff; J Wang; R Lee; M M Qureshi; S Jalisi; O Sakai
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-14       Impact factor: 3.825

2.  An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.

Authors:  Sotirios Bisdas; Oliver Seitz; Markus Middendorp; Nicole Chambron-Pinho; Theodosios Bisdas; Thomas J Vogl; Renate Hammerstingl; Ulrike Ernemann; Martin G Mack
Journal:  Eur Radiol       Date:  2010-05-05       Impact factor: 5.315

3.  The value of perfusion CT in predicting the short-term response to synchronous radiochemotherapy for cervical squamous cancer.

Authors:  Xiang Sheng Li; Hong Xia Fan; Hong Xian Zhu; Yun Long Song; Chun Wu Zhou
Journal:  Eur Radiol       Date:  2011-09-30       Impact factor: 5.315

4.  CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy.

Authors:  Subha Perni; Abdallah S R Mohamed; Jacob Scott; Heiko Enderling; Adam S Garden; G Brandon Gunn; David I Rosenthal; Clifton D Fuller
Journal:  Oral Oncol       Date:  2016-11-04       Impact factor: 5.337

Review 5.  Multiparametric PET/CT in oncology.

Authors:  Dalveer Singh; Kenneth Miles
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

Review 6.  Role of CT perfusion in monitoring and prediction of response to therapy of head and neck squamous cell carcinoma.

Authors:  Lorenzo Preda; Sonia Francesca Calloni; Marco Elvio Manlio Moscatelli; Maria Cossu Rocca; Massimo Bellomi
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

Review 7.  Assessing Tumor Response to Treatment in Patients with Lung Cancer Using Dynamic Contrast-Enhanced CT.

Authors:  Louise S Strauch; Rie Ø Eriksen; Michael Sandgaard; Thomas S Kristensen; Michael B Nielsen; Carsten A Lauridsen
Journal:  Diagnostics (Basel)       Date:  2016-07-21

8.  Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.

Authors:  Natalie M Lowe; Lucy E Kershaw; Jonathan M Bernstein; Stephanie B Withey; Kathleen Mais; Jarrod J Homer; Nicholas J Slevin; Suzanne C Bonington; Bernadette M Carrington; Catharine M West
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

Review 9.  Predicting tumour response.

Authors:  Samuel D Kyle; W Phillip Law; Kenneth A Miles
Journal:  Cancer Imaging       Date:  2013-09-23       Impact factor: 3.909

10.  Multiparametric imaging using 18F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Authors:  Sheng-Chieh Chan; Nai-Ming Cheng; Chia-Hsun Hsieh; Shu-Hang Ng; Chien-Yu Lin; Tzu-Chen Yen; Cheng-Lung Hsu; Hung-Ming Wan; Chun-Ta Liao; Kai-Ping Chang; Jiun-Jie Wang
Journal:  Oncotarget       Date:  2017-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.